← Back to Search

Physiotherapy for Urinary Incontinence in Gynecologic Cancer Survivors

N/A

Recruiting

Research Sponsored by Université de Sherbrooke

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Scheduled oncological treatments completed

Stress or mixed urinary incontinence with a frequency of at least three urinary leakage per

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 2-week post-treatment

Awards & highlights

Study Summary

This trial is testing whether a certain type of physical therapy can help treat urinary incontinence in cancer survivors.

Who is the study for?

This trial is for women who have survived gynecological cancers like endometrial or cervical cancer and are now experiencing urinary incontinence at least three times a week. They should be done with their scheduled cancer treatments but haven't had pelvic floor rehab in the past year, and don't have other conditions that could affect the study.Check my eligibility

What is being tested?

The study is testing physiotherapy as a treatment for urinary incontinence against standard care given to survivors of gynecological cancers. It's a pilot study meant to set up for a larger future trial by checking how feasible this approach is.See study design

What are the potential side effects?

Since this trial involves physiotherapy, side effects might include temporary soreness or muscle fatigue from exercises. Unlike drug trials, there's less risk of systemic side effects since it's non-invasive.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have finished all my planned cancer treatments.

Select...

I experience urinary leakage at least three times a week.

Select...

I have had cancer in my reproductive organs.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 2-week post-treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 2-week post-treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 2-week post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence rates

Retention rate

Secondary outcome measures

Change from baseline in number of urinary leaks

Change from baseline in pelvic floor muscle function

Change from baseline in pelvic floor muscle morphometry

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PhysiotherapyExperimental Treatment1 Intervention

12-weekly physiotherapy treatment sessions.

Group II: Standard usual careActive Control1 Intervention

Participants will be asked to continue the usual care established during the regular follow-up with their medical doctor for 12 weeks.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)OTHER

369 Previous Clinical Trials

129,794 Total Patients Enrolled

Université de SherbrookeLead Sponsor

298 Previous Clinical Trials

69,897 Total Patients Enrolled

3 Trials studying Urinary Incontinence

198 Patients Enrolled for Urinary Incontinence

Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER

60 Previous Clinical Trials

31,157 Total Patients Enrolled

2 Trials studying Urinary Incontinence

78 Patients Enrolled for Urinary Incontinence

Media Library

Physiotherapy Clinical Trial Eligibility Overview. Trial Name: NCT03957434 — N/A

Urinary Incontinence Research Study Groups: Physiotherapy, Standard usual care

Urinary Incontinence Clinical Trial 2023: Physiotherapy Highlights & Side Effects. Trial Name: NCT03957434 — N/A

Physiotherapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03957434 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the demographic for this research encompass individuals over 50 years old?

"This medical trial's inclusion requirements states that all candidates must be between ages 18 and 80. Separately, 19 trials are available for individuals younger than 18 while 196 studies cater to persons above 65 years old."

Answered by AI

What objective is this clinical trial striving to achieve?

"The aim of this trial, assessed over a two-week period from baseline measurements, is to determine adherence rates. Secondary objectives include surveying morphometric alterations in pelvic floor muscles via ultrasound imaging, evaluating muscle function at rest and during contraction with dynamometry, and assessing any changes in sexual performance through the Female Sexual Function Index (FSFI) score range of 2-36; low scores indicating diminished functionality."

Answered by AI

What is the intake capacity of this trial?

"Affirmative, the information hosted on clinicaltrials.gov states that this experiment is currently recruiting subjects. It was promulgated on October 16th 2018 and most recently updated January 26th 2022. A total of 44 research participants are needed at one site."

Answered by AI

Who is eligible to take part in this exploration?

"Those seeking to be included in this clinical trial must have urinary incontinence and should fall between 18-80 years of age. Currently, 44 individuals are being recruited for the study."

Answered by AI

Are there still openings in this research program for participants?

"Correct. According to clinicaltrials.gov, this research is seeking participants as of January 26th 2022, having been initially posted on October 16th 2018. 44 individuals are needed from a single location for the trial's completion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Physiotherapy Treatment for Gynecological Cancer Survivors With Urinary Incontinence

Mélanie Morin 2018. "Physiotherapy Treatment for Gynecological Cancer Survivors With Urinary Incontinence". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03957434.

All > Urinary Incontinence